高密度脂蛋白2b与顺序器官衰竭评估得分相结合,作为败血症患者的新预后指标:一项前性研究
Yuting Chen1, Yichun Jiang1, Andi Xia1
1Department of Critical Medicine, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medicine College of Jinan University, No. 1017, Dongmen Northern Road, Shenzhen, 518020, PR China.
BMC infectious diseases
|December 30, 2025
概括
高密度脂蛋白2b (HDL2b) 水平和顺序器官衰竭评估 (SOFA) 评分的结合可靠地预测短期败血症死亡率. 这一综合得分在识别有风险的患者方面,与单独使用SOFA相比,显示出更高的准确性.
科学领域:
- 关键护理医学 关键护理医学
- 生物标志物 生物标志物
- 预测指标的预测指标
背景情况:
- 败血症是一种危及生命的疾病,其特点是由于宿主对感染的反应失调而导致器官功能障碍.
- 它经常导致器官衰竭和死亡.
- 对败血症结果的早期和准确预测对于及时干预至关重要.
研究的目的:
- 为了评估血高密度脂蛋白2b (HDL2b) 水平的预测值.
- 为了评估顺序性器官衰竭评估 (SOFA) 评分的预后能力.
- 确定HDL2b和SOFA对短期败血症死亡率的联合预测能力.
主要方法:
- 一项前性观察性研究,涉及败血症患者和非败血症对照.
- 使用微流体芯片技术测量血HDL2b水平.
- 计算SOFA分数和接受者-操作者特征 (ROC) 曲线分析以预测死亡率.
主要成果:
- 与对照组相比,败血症患者的HDL2b水平显著降低.
- 没有幸存者的HDL2b水平低于幸存者的HDL2b水平.
- 综合的HDL2b+SOFA得分在预测28天和住院死亡率 (曲线下的面积:0.806) 中比单独的SOFA (0.782) 或单独的HDL2b (0.755) 更准确.
结论:
- HDL2b + SOFA复合评分是败血症短期死亡率的可靠预测指标.
- 与单独的SOFA得分相比,这种综合得分提供了更强大的歧视能力.
- 这些发现表明,可以将HDL2b整合到败血症预后工具中.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...